Clever bio-inks that sit inside the human body and restore damaged neurons could cure a whole swathe of eye diseases in the next 20

Richard Wylie, Chief Executive Officer of Glaucoma Australia, has resigned after 21 months in the position.

EssilorLuxottica has launched a new partnership program, EssilorLuxottica 360 (EL360), which it says will give independent optometry practices more opportunity to grow.

Bausch and Lomb has launched a novel daily nutritional supplement for dry eye in the United States after a successful clinical study.